- Home
- BLDR vs GH Comparison
BLDR vs GH Comparison
Compare BLDR & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLDR | GH |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 13.3B |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BLDR | GH |
|---|---|---|
| Price | $85.30 | $85.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 19 |
| Target Price | ★ $127.35 | $119.79 |
| AVG Volume (30 Days) | 1.8M | ★ 2.0M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.74 |
| EPS | ★ 3.89 | N/A |
| Revenue | ★ $15,190,638,000.00 | $982,021,000.00 |
| Revenue This Year | $0.88 | $33.30 |
| Revenue Next Year | $4.64 | $28.19 |
| P/E Ratio | $22.62 | ★ N/A |
| Revenue Growth | N/A | ★ 32.88 |
| 52 Week Low | $76.50 | $36.36 |
| 52 Week High | $151.03 | $120.74 |
Technical Indicators
Market Signals| Indicator | BLDR | GH |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | 45.17 |
| Support Level | $78.25 | $82.33 |
| Resistance Level | $130.47 | $90.28 |
| Average True Range (ATR) | 3.72 | 5.44 |
| MACD | 1.59 | -0.07 |
| Stochastic Oscillator | 68.96 | 43.78 |
Price Performance
Historical ComparisonAbout BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.